Keywords: gsk, pakistan, profits, leap, glaxosmithkline, bangladesh, reported
GSK Pakistan profits leap 33%
Article | 26 May 2003
GlaxoSmithKline Bangladesh has reported a 32.9% rise in net profit to 72.2 million taka ($1.2 million) for 2002, said Sarwar Khan, a director of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
